P626: A PHASE 1 STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY ANTITUMOR ACTIVITY OF BCL-2 INHIBITOR BGB-11417 IN ADULT PATIENTS WITH MATURE B-CELL MALIGNANCIES

Detalles Bibliográficos
Autores principales: LI, Caixia, Wei, Jia, Peng, Liu, Huang, He, LI, Fei, Dong, Yujun, Cai, Qingqing, Yang, Shenmiao, Zhang, Xinyou, Zhou, Hui, Zhang, Lu, Shi, Zaixing, Liang, Zhiyu, Wu, Binghao, Zhou, Keshu, Wu, Depei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429549/
http://dx.doi.org/10.1097/01.HS9.0000969408.27108.10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429549/
http://dx.doi.org/10.1097/01.HS9.0000969408.27108.10

Ejemplares similares